Aztreonam Patent Expiration
Aztreonam is Used for improving respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. It was first introduced by Bristol Myers Squibb
Aztreonam Patents
Given below is the list of patents protecting Aztreonam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cayston | US7208141 | Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
Dec 20, 2021
(Expired) | Gilead |
| Cayston | US7214364 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
Dec 20, 2021
(Expired) | Gilead |
| Cayston | US7427633 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
Dec 20, 2021
(Expired) | Gilead |
| Cayston | US8399496 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
Dec 20, 2021
(Expired) | Gilead |
Aztreonam's Family Patents
Explore Our Curated Drug Screens
Aztreonam Generic API Manufacturers
Several generic applications have been filed for Aztreonam. The first generic version for Aztreonam was by Fresenius Kabi Usa Llc and was approved on Jun 18, 2010. And the latest generic version is by Hospira Inc and was approved on Nov 8, 2021.
Given below is the list of companies who have filed for Aztreonam generic, along with the locations of their manufacturing plants worldwide.
1. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 3 different strengths of generic version for Aztreonam. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | N/A | Jun 18, 2010 |
| 2GM/VIAL | injectable | Prescription | INJECTION | AP | Jun 18, 2010 |
| 1GM/VIAL | injectable | Prescription | INJECTION | AP | Jun 18, 2010 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
2. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Aztreonam. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM/VIAL | injectable | Discontinued | INJECTION | N/A | Mar 23, 2011 |
| 2GM/VIAL | injectable | Discontinued | INJECTION | N/A | Mar 23, 2011 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
3. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Aztreonam. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM/VIAL | injectable | Prescription | INJECTION | AP | Nov 8, 2021 |
| 2GM/VIAL | injectable | Prescription | INJECTION | AP | Nov 8, 2021 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||